Tightly regulated gene expression in human hematopoietic stem cells after transduction with helper-dependent Ad5/35 vectors

Experimental Hematology

Volumn 36, Issue 7, 2008, Pages 823-831

  Wang, Hongje ^a   Cao, Hua ^a   Wohlfahrt, Martin ^c   Kiem, Hans Peter ^c   Lieber, André ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR;

ANIMAL CELL; ARTICLE; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOTOXICITY; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; TRANSGENE;

ADENOVIRIDAE; ANTIGENS, CD34; CELL LINE; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; TRANSDUCTION, GENETIC; TRANSGENES;

ADENOVIRIDAE; MUS;

EID: 52449135479     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2008.01.014     Document Type: Article

References (31)

1. Wang H., and Lieber A. A helper-dependent capsid-modified adenovirus vector expressing adeno-associated virus rep78 mediates site-specific integration of a 27-kilobase transgene cassette. J Virol 80 (2006) 11699-11709
2. Miller J.C., Holmes M.C., Wang J., et al. An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol 25 (2007) 778-785
3. Yanez-Munoz R.J., Balaggan K.S., MacNeil A., et al. Effective gene therapy with nonintegrating lentiviral vectors. Nat Med 12 (2006) 348-353
4. Shayakhmetov D.M., Papayannopoulou T., Stamatoyannopoulos G., and Lieber A. Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector. J Virol 74 (2000) 2567-2583
5. Gaggar A., Shayakhmetov D., and Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat Med 9 (2003) 1408-1412
6. Yotnda P., Onishi H., Heslop H.E., et al. Efficient infection of primitive hematopoietic stem cells by modified adenovirus. Gene Ther 8 (2001) 930-937
7. Nilsson M., Karlsson S., and Fan X. Functionally distinct subpopulations of cord blood CD34+ cells are transduced by adenoviral vectors with serotype 5 or 35 tropism. Mol Ther 9 (2004) 377-388
8. Lieber A., He C.Y., Kirillova I., and Kay M.A. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo. J Virol 70 (1996) 8944-8960
9. Kochanek S., Schiedner G., and Volpers C. High-capacity 'gutless' adenoviral vectors. Curr Opin Mol Ther 3 (2001) 454-463
10. Wang H., Shayakhmetov D.M., Leege T., et al. A capsid-modified helper-dependent adenovirus vector containing the beta-globin locus control region displays a nonrandom integration pattern and allows stable, erythroid-specific gene expression. J Virol 79 (2005) 10999-11013
11. Balamotis M.A., Huang K., and Mitani K. Efficient delivery and stable gene expression in a hematopoietic cell line using a chimeric serotype 35 fiber pseudotyped helper-dependent adenoviral vector. Virology 324 (2004) 229-237
12. Hearing P, Shenk T. The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element. Cell. 33:695-703.
13. Grable M., and Hearing P. cis and trans requirements for the selective packaging of adenovirus type 5 DNA. J Virol 66 (1992) 723-731
14. Shi Q., Wang Y., and Worton R. Modulation of the specificity and activity of a cellular promoter in an adenoviral vector. Hum Gene Ther 8 (1997) 403-410
15. Friedman J.M., Babiss L.E., Clayton D.F., and Darnell Jr. J.E. Cellular promoters incorporated into the adenovirus genome: cell specificity of albumin and immunoglobulin expression. Mol Cell Biol 6 (1986) 3791-3797
16. Xu Z.L., Mizuguchi H., Mayumi T., and Hayakawa T. Regulated gene expression from adenovirus vectors: a systematic comparison of various inducible systems. Gene 309 (2003) 145-151
17. Salucci V., Scarito A., Aurisicchio L., et al. Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2(s)-M2 tetracycline transactivator and repressor system. Gene Ther 9 (2002) 1415-1421
18. Steinwaerder D.S., and Lieber A. Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo. Gene Ther 7 (2000) 556-567
19. Ye X., Liang M., Meng X., et al. Insulation from viral transcriptional regulatory elements enables improvement to hepatoma-specific gene expression from adenovirus vectors. Biochem Biophys Res Commun 307 (2003) 759-764
20. Majem M., Cascallo M., Bayo-Puxan N., Mesia R., Germa J.R., and Alemany R. Control of E1A under an E2F-1 promoter insulated with the myotonic dystrophy locus insulator reduces the toxicity of oncolytic adenovirus Ad-Delta24RGD. Cancer Gene Ther 13 (2006) 696-705
21. Hallenbeck P.L., Chang Y.N., Hay C., et al. A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma. Hum Gene Ther 10 (1999) 1721-1733
22. Szulc J., Wiznerowicz M., Sauvain M.O., Trono D., and Aebischer P. A versatile tool for conditional gene expression and knockdown. Nat Methods 3 (2006) 109-116
23. Gossen M., Freundlieb S., Bender G., Muller G., Hillen W., and Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science 268 (1995) 1766-1769
24. Hartigan-O'Connor D., Barjot C., Salvatori G., and Chamberlain J.S. Generation and growth of gutted adenoviral vectors. Methods Enzymol 346 (2002) 224-246
25. Barjot C., Hartigan-O'Connor D., Salvatori G., Scott J.M., and Chamberlain J.S. Gutted adenoviral vector growth using E1/E2b/E3-deleted helper viruses. J Gene Med 4 (2002) 480-489
26. Avanzi G.C., Lista P., Giovinazzo B., et al. Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features. Br J Haematol 69 (1988) 359-366
27. Sandig V., Youil R., Bett A.J., et al. Optimization of the helper-dependent adenovirus system for production and potency in vivo. Proc Natl Acad Sci U S A 97 (2000) 1002-1007
28. Moosmann P., Georgiev O., Thiesen H.J., Hagmann M., and Schaffner W. Silencing of RNA polymerases II and III-dependent transcription by the KRAB protein domain of KOX1, a Kruppel-type zinc finger factor. Biol Chem 378 (1997) 669-677
29. Tate V.E., and Philipson L. Parental adenovirus DNA accumulates in nucleosome-like structures in infected cells. Nucleic Acids Res 6 (1979) 2769-2785
30. Mirza M.A., and Weber J. Structure of adenovirus chromatin. Biochim Biophys Acta 696 (1982) 76-86
31. Carlson C.A., Shayakhmetov D.M., and Lieber A. An adenoviral expression system for AAV Rep78 using homologous recombination. Mol Ther 6 (2002) 91-98